These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15045123)

  • 1. Beyond cholesterol: the enigma of atherosclerosis revisited.
    Bhakdi S; Lackner KJ; Han SR; Torzewski M; Husmann M
    Thromb Haemost; 2004 Apr; 91(4):639-45. PubMed ID: 15045123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunopathogenesis of atherosclerosis: the Mainz hypothesis].
    Bhakdi S
    Med Monatsschr Pharm; 2006 Oct; 29(10):356-9. PubMed ID: 17058894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiation and progression of atherosclerosis--enzymatic or oxidative modification of low-density lipoprotein?
    Torzewski M; Lackner KJ
    Clin Chem Lab Med; 2006; 44(12):1389-94. PubMed ID: 17163812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement and atherosclerosis-united to the point of no return?
    Torzewski M; Bhakdi S
    Clin Biochem; 2013 Jan; 46(1-2):20-5. PubMed ID: 23010447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An alternative hypothesis of the pathogenesis of atherosclerosis].
    Bhakdi S
    Herz; 1998 May; 23(3):163-7. PubMed ID: 9646097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Initial Human Atherosclerotic Lesion and Lipoprotein Modification-A Deep Connection.
    Torzewski M
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis.
    Torzewski M; Suriyaphol P; Paprotka K; Spath L; Ochsenhirt V; Schmitt A; Han SR; Husmann M; Gerl VB; Bhakdi S; Lackner KJ
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2130-6. PubMed ID: 15345515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement and atherogenesis: the unknown connection.
    Bhakdi S
    Ann Med; 1998 Dec; 30(6):503-7. PubMed ID: 9920350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential protective role of apoprotein J (clusterin) in atherogenesis: binding to enzymatically modified low-density lipoprotein reduces fatty acid-mediated cytotoxicity.
    Schwarz M; Spath L; Lux CA; Paprotka K; Torzewski M; Dersch K; Koch-Brandt C; Husmann M; Bhakdi S
    Thromb Haemost; 2008 Jul; 100(1):110-8. PubMed ID: 18612545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia.
    Boullier A; Hennuyer N; Tailleux A; Furman C; Duverger N; Caillaud JM; Castro G; Fievet C; Fruchart JC; Duriez P
    Clin Sci (Lond); 2001 Mar; 100(3):343-55. PubMed ID: 11222122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of atherosclerosis: infectious versus immune pathogenesis. A new concept.
    Bhakdi S
    Herz; 2000 Mar; 25(2):84-6. PubMed ID: 10829244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific recognition of malondialdehyde and malondialdehyde acetaldehyde adducts on oxidized LDL and apoptotic cells by complement anaphylatoxin C3a.
    Veneskoski M; Turunen SP; Kummu O; Nissinen A; Rannikko S; Levonen AL; Hörkkö S
    Free Radic Biol Med; 2011 Aug; 51(4):834-43. PubMed ID: 21683785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence.
    Bhakdi S; Torzewski M; Paprotka K; Schmitt S; Barsoom H; Suriyaphol P; Han SR; Lackner KJ; Husmann M
    Circulation; 2004 Apr; 109(15):1870-6. PubMed ID: 15037531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rethinking oxidized low-density lipoprotein, its role in atherogenesis and the immune responses associated with it.
    Shaw PX
    Arch Immunol Ther Exp (Warsz); 2004; 52(4):225-39. PubMed ID: 15467487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of modified oxidation of low density lipoprotein in pathognesis of atherosclerosis].
    Siennicka A; Zapolska-Downar D
    Postepy Hig Med Dosw; 2003; 57(2):219-37. PubMed ID: 12866357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants.
    Aviram M
    Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):599-608. PubMed ID: 8877334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum lipoprotein and atherogenicity--relationship with particle size and composition of low density lipoproteins, and their modifications by oxidation and glycation].
    Takeuchi N; Saheki S
    Rinsho Byori; 1995 Aug; 43(8):753-62. PubMed ID: 7474432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatically modified LDL, atherosclerosis and beyond: paving the way to acceptance.
    Torzewski M
    Front Biosci (Landmark Ed); 2018 Jan; 23(7):1257-1271. PubMed ID: 28930598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies.
    Napoli C
    G Ital Cardiol; 1997 Dec; 27(12):1302-14. PubMed ID: 9470066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.